3 High-Growth Tech Stocks to Buy and Hold

Rising bond yields have sparked a rotation from growth to value stocks over the past two months. As a result, many tech stocks that dazzled growth-oriented investors throughout the pandemic

  Read more »

Should AbbVie Be Worried About Rinvoq?

The U.S. Food and Drug Administration (FDA) has now pushed back two reviews for regulatory filings by AbbVie (NYSE: ABBV) for Rinvoq. This autoimmune disease drug is an important component

  Read more »

The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance

Illumina (NASDAQ: ILMN) delivered a pleasant surprise earlier this month with its revenue growth projected for the first quarter and for full-year 2021. In this Motley Fool Live video recorded

  Read more »

5 Reasons to Refinance Your Auto Loan

Image source: Getty Images The moment interest rates drop, the mortgage refinancing buzz begins. Yet we rarely hear anything about refinancing auto loans. It may be because homes are more

  Read more »

Should You Buy Zomedica in April?

Zomedica (NYSEMKT: ZOM) has been one of the hottest stocks of 2021, soaring more than 340% this year and dwarfing the S&P 500 and its 10% gains in the process.

  Read more »

Is Morphic Holding a Buy?

On March 1, Morphic Holding‘s (NASDAQ: MORF) stock more than doubled after the company announced interim phase 1 data on its experimental therapy, MORF-057. That’s a pretty significant pop for

  Read more »